BioPorto Income Statement

Financials in millions DKK. Fiscal year is January - December.

Millions DKK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	36.56	36.24	30.96	28.97	24.25	23.2
Revenue Growth (YoY)	4.74%	17.07%	6.87%	19.44%	4.52%	-12.84%
Cost of Revenue	13.2	11.71	10.78	9.93	9.21	9.87
Gross Profit	23.36	24.53	20.18	19.04	15.04	13.34
Selling, General & Admin	60.34	63.05	54.9	63.05	50.04	48.8
Research & Development	50.4	33.53	25.45	34.94	30.26	28.13
Operating Expenses	110.74	96.58	80.35	97.99	80.3	76.93
Operating Income	-87.38	-72.05	-60.16	-78.94	-65.26	-63.59
Interest Expense	-1.52	-0.45	-0.57	-1.09	-0.91	-0.78
Interest & Investment Income	1.04	1.64	1.04	0.04	-	0
Currency Exchange Gain (Loss)	0.9	0.9	-0.43	1.14	2.46	-2.4
Other Non Operating Income (Expenses)	-0.38	-0.38	-0.07	-0.12	-0.13	-0.07
EBT Excluding Unusual Items	-87.34	-70.34	-60.2	-78.96	-63.84	-66.83
Asset Writedown	-	-	-1.01	-2.58	-	-
Other Unusual Items	-6	-3.4	-	-	-	-
Pretax Income	-93.34	-73.74	-61.21	-81.55	-63.84	-66.83
Income Tax Expense	-6.54	-5.5	-4.88	-5.62	-6.73	-5.27
Net Income	-86.8	-68.24	-56.33	-75.92	-57.11	-61.56
Net Income to Common	-86.8	-68.24	-56.33	-75.92	-57.11	-61.56
Shares Outstanding (Basic)	441	406	358	319	267	205
Shares Outstanding (Diluted)	441	406	358	319	267	205
Shares Change (YoY)	12.04%	13.18%	12.54%	19.11%	30.21%	20.53%
EPS (Basic)	-0.20	-0.17	-0.16	-0.24	-0.21	-0.30
EPS (Diluted)	-0.20	-0.17	-0.16	-0.24	-0.21	-0.30
Free Cash Flow	-81.36	-83.93	-55.5	-52.89	-64.71	-36.93
Free Cash Flow Per Share	-0.18	-0.21	-0.15	-0.17	-0.24	-0.18
Gross Margin	63.90%	67.68%	65.19%	65.73%	62.01%	57.49%
Operating Margin	-238.98%	-198.80%	-194.34%	-272.51%	-269.05%	-274.05%
Profit Margin	-237.40%	-188.29%	-181.95%	-262.08%	-235.48%	-265.31%
Free Cash Flow Margin	-222.53%	-231.58%	-179.26%	-182.58%	-266.79%	-159.16%
EBITDA	-86.54	-71.36	-59.16	-77.81	-64.2	-62.73
EBITDA Margin	-236.70%	-196.90%	-191.09%	-268.60%	-264.70%	-270.33%
D&A For EBITDA	0.84	0.69	1.01	1.13	1.05	0.86
EBIT	-87.38	-72.05	-60.16	-78.94	-65.26	-63.59
EBIT Margin	-238.98%	-198.80%	-194.34%	-272.51%	-269.05%	-274.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.